Ameriprise Financial Inc / VRTX
Ameriprise Financial Inc’s Vertex Pharmaceuticals Inc Position
Does Ameriprise Financial Inc own Vertex Pharmaceuticals Inc (VRTX)? Yes — 2.63M shares worth $1.2B (+0.27% of its 13F portfolio) as of Q1 2026, up from 2.26M shares the prior filed quarter.
Position Value
$1.2B
Q1 2026
Shares
2.63M
% of Portfolio
+0.27%
Quarters Held
25
currently held
Position History VRTX
Reported value by quarter
| Quarter | Shares | Value | % of Portfolio |
|---|---|---|---|
| Q1 2026 | 2.63M | $1.2B | +0.27% |
| Q4 2025 | 2.26M | $1.0B | +0.23% |
| Q3 2025 | 2.28M | $892M | +0.20% |
| Q2 2025 | 2.18M | $971M | +0.24% |
| Q1 2025 | 2.24M | $1.1B | +0.29% |
| Q4 2024 | 2.02M | $812M | +0.21% |
| Q3 2024 | 1.87M | $871M | +0.22% |
| Q2 2024 | 2.05M | $963M | +0.26% |
| Q1 2024 | 2.23M | $930M | +0.26% |
| Q4 2023 | 2.51M | $1.0B | +0.31% |
| Q3 2023 | 2.94M | $1.0B | +0.34% |
| Q2 2023 | 3.02M | $1.1B | +0.33% |
| Q1 2023 | 3.39M | $1.1B | +0.35% |
| Q4 2022 | 3.58M | $1.0B | +0.35% |
| Q3 2022 | 4.04M | $1.2B | +0.43% |
| Q2 2022 | 4.56M | $1.3B | +0.45% |
| Q1 2022 | 4.95M | $1.3B | +0.38% |
| Q4 2021 | 4.42M | $969M | +0.27% |
| Q3 2021 | 3.39M | $615M | +0.20% |
| Q2 2021 | 2.74M | $552M | +0.17% |
| Q1 2021 | 1.92M | $412M | +0.14% |
| Q4 2020 | 817.6K | $193M | +0.07% |
| Q3 2020 | 839.9K | $228M | +0.09% |
| Q2 2020 | 1.28M | $373M | +0.16% |
| Q1 2020 | 2.17M | $517M | +0.27% |
Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Ameriprise Financial Inc’s full portfolio or all institutional holders of VRTX.